Overall, the upregulation of C12orf75 expression promoted tumor progression in BLCA, LIHC, and UVM, while it seemed to be related with a better prognosis in KIRP patients (Figure 2A–2L). This evidence concerns the gene C12orf75 and bladder transitional cell carcinoma.